User:Mr. Ibrahem/Ospemifene

Ospemifene, sold under the brand names Osphena and Senshio, is a medication used to treat vaginal atrophy in women after menopause. It is used when estrogen cannot be applied. It is taken by mouth.

Common side effects include vaginal candidiasis, hot flushes, headache, muscle spasms, rash, and vaginal bleeding. It should not be used in people with breast cancer or venous thromboembolism. It is a selective estrogen receptor modulator (SERM). It acts similarly to estrogen on the vagina.

Ospemifene was approved for medical use in the United States in 2013 and Europe in 2015. In the United Kingdom 4 weeks of treatment costs the NHS about £40. This amount in the United States is about 210 USD.